Top industry execs share their views on the most pressing issues: What are the challenges everyone’s thinking about? and what trends must we respond to in developing drugs and negotiating supply ecosystems? Who’s got the best solutions?

This 2 part virtual event will focus on small and large molecules and will help you decide who to meet in Frankfurt, and focus your discussions at the show! They’ll feature the thoughts of c-suite industry executives, experienced developers, specialists, consultants, and industry KOLs.

To prepare us for the industry’s biggest event, rapid fire presentations from the most innovative CDMO leaders on what’s needed and how they are building their vision for the industry’s future.

Small Molecule: Top Pharma Execs on Burning Challenges and Promising Solutions to Explore

Speakers:

John Chiminski, Board Director & Former CEO

Gil Roth, President, PBOA

Elliott Berger, Member, Board of Directors and Strategic Advisor, Orientation Marketing

Steven Facer, Senior Vice President, Global Sales and Marketing, Adare Pharma Solutions

Jeremie Trochu, CEO, Ardena

Yann D’Herve, CEO – CDMO Business, Cohance Lifesciences

Register here.

Large Molecules and New Modalities: Top Pharma Execs on Burning Challenges and Promising Solutions to Explore

Speakers:

John Chiminski, Board Director & Former CEO

Julien Meissonnier, Senior Advisor

Gil Roth, President, PBOA

Elliott Berger, Member, Board of Directors and Strategic Advisor, Orientation Marketing

Mark DaFonseca, Chief Commercial Officer, Lifecore

Eduard Viladesau, Managing Director, HIPRA Biotech Services

Isabel Feuerstein, Head of Business Development Europe & Asia CDMO, Novartis Contract Manufacturing

Jonathan Haigh, Head of UK Sites, FUJIFILM Biotechnologies

Register here.